Concepedia

Arlene S. Swern

AS

34

Publications

1.5K

Citations

21

H-Index

1995

Active since

Affiliations

Emory University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Dana-Farber Cancer Institute

NorthShore University HealthSystem

The University of Texas MD Anderson Cancer Center

Arlene S. Swern is an author at Emory University specializing in medicine, oncology, and hematology.

Top concepts

Publications per year

1995–2021

34

Publications

34

Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study

María Luz García‐García, Ulrich Wahn, Leen Gilles et al. · PEDIATRICS · 2005 · 184 citations

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

Steven D. Gore, Pierre Fenaux, Valeria Santini et al. · Haematologica · 2013 · 133 citations · Full text

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

Debora Williams‐Herman, Elizabeth Round, Arlene S. Swern et al. · BMC Endocrine Disorders · 2008 · 130 citations · Full text

Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial

David Price, Arlene S. Swern, Carol A. Tozzi et al. · Allergy · 2006 · 123 citations

Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T 1 a,b NO MO)

Stuart P. Leitner, Arlene S. Swern, Daniela Weinberger et al. · Cancer · 1995 · 123 citations · Full text

Rows per page

1–5 of 34